Copyright
©The Author(s) 2021.
World J Clin Cases. Jun 16, 2021; 9(17): 4133-4142
Published online Jun 16, 2021. doi: 10.12998/wjcc.v9.i17.4133
Published online Jun 16, 2021. doi: 10.12998/wjcc.v9.i17.4133
Figure 1 Interwoven relationships between nonalcoholic fatty liver disease, coronavirus disease 2019, interleukin-6, risk factors for coronavirus disease 2019, and effect of lockdown.
The risk factors for coronavirus disease 2019 (COVID-19) are infection, lung injury, liver fibrosis, and cardiac impairment. IL-6: Interleukin–6; NAFLD: Nonalcoholic fatty liver disease.
- Citation: Ahmed M, Ahmed MH. Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic. World J Clin Cases 2021; 9(17): 4133-4142
- URL: https://www.wjgnet.com/2307-8960/full/v9/i17/4133.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i17.4133